Patents by Inventor Philip David DORGAN

Philip David DORGAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240315984
    Abstract: The present disclosure pertains to biodegradable polymeric microspheres that comprise a biodegradable polymer and an immunotherapeutic agent selected from an inhibitor of poly ADP ribose polymerase enzyme (PARP inhibitor) and/or a Toll-like receptor (TLR) agonist wherein (a) 50% of a total amount of the immunotherapeutic agent in the biodegradable polymeric microspheres is released from the biodegradable polymeric microspheres into a 37° C. solution of PBS Tween 20 (0.05%) at a point in time ranging from 3 days and 14 days; (b) between 1 mg and 100 mg of immunotherapeutic agent per 1 g dry weight of microspheres is released from the biodegradable polymeric microspheres into a 37° C. solution of PBS Tween 20 (0.05%) at a point in time ranging from 3 days and 14 days; or (c) both (a) and (b). Other aspects of the present disclosure pertain to methods of using such microparticles and kits that contain such microparticles.
    Type: Application
    Filed: March 21, 2024
    Publication date: September 26, 2024
    Applicant: Boston Scientific Scimed, Inc.
    Inventors: Bhanu Prasanth Koppolu, Philip David Dorgan, Rhiannon Johnson, Steven L. Kangas, Nivedita Swetha Ramkumar, Matthew R. Dreher
  • Publication number: 20230355834
    Abstract: In some aspects, the present disclosure pertains to injectable polysaccharide-based hydrogels that comprises an anionic polysaccharide, a cationic crosslinking agent and a hemostatic agent. In some aspects, the present disclosure pertains to medical devices containing such injectable polysaccharide-based hydrogels, to kits that contain such injectable polysaccharide-based hydrogels, and to methods of using such injectable polysaccharide-based hydrogels.
    Type: Application
    Filed: May 2, 2023
    Publication date: November 9, 2023
    Applicant: BOSTON SCIENTIFIC SCIMED, INC.
    Inventors: Philip David Dorgan, Edward Joseph Devlin, Conor O’Sullivan, John Murphy, Mark Looney, Paul O’Farrell
  • Publication number: 20220313603
    Abstract: The present disclosure pertains to therapeutic hydrogels that comprise an anionic polysaccharide crosslinked by a branched polyamine, wherein the branched polyamine comprises at least two primary amine groups, more typically at least three primary amine groups. The present disclosure also pertains to medical compositions that comprise such therapeutic hydrogels and to methods of medical treatment in which such therapeutic hydrogels are delivered to a patient in need of medical treatment.
    Type: Application
    Filed: April 5, 2022
    Publication date: October 6, 2022
    Applicant: Boston Scientific Scimed Inc.
    Inventors: Viktoria Molnar, Carolina Villarreal, Bhanu Prasanth Koppolu, Nivedita Swetha Ramkumar, Philip David Dorgan
  • Publication number: 20130324456
    Abstract: The present invention is a spray-dried powder comprising: at least 5 wt % of a spray-dried particle comprising at least 40 wt % anionic detersive surfactant, from 15 to 40 wt % carbonate and less than 20 wt % sulphate and having a bulk density of from 300 g/l to 450 g/l.
    Type: Application
    Filed: May 30, 2013
    Publication date: December 5, 2013
    Inventors: Hossam Hassan TANTAWY, Adam PORTER, Philip David DORGAN